)
ALX Oncology (ALXO) investor relations material
ALX Oncology AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
CEO welcomed attendees, introduced directors, nominees, and management, and emphasized the benefits of a virtual meeting format.
Outside counsel, independent auditor, and Inspector of Election were introduced.
Agenda included election of directors, advisory vote on executive compensation, and ratification of the auditor.
Shareholder proposals
Stockholders voted on electing three Class III directors to serve until 2029.
Advisory vote held on executive compensation as disclosed in the proxy statement.
Ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2026.
Overview of voting outcomes
All three director nominees were elected.
Advisory vote on executive compensation was approved.
Appointment of KPMG LLP as auditor was ratified.
- Evorpacept and ALX2004 advance with strong data, robust funding, and pivotal trials planned.ALXO
Jefferies Global Healthcare Conference 20263 Jun 2026 - 100% response in CD47-high, HER2+ breast cancer; $169.1M cash supports 2026–2027 milestones.ALXO
Q1 202614 May 2026 - Virtual meeting to vote on directors, executive pay, and auditor, with strong governance oversight.ALXO
Proxy filing20 Apr 2026 - Evorpacept and ALX2004 advance with strong data, new biomarkers, and pivotal trials ahead.ALXO
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Evorpacept and ALX2004 advance toward key clinical milestones, targeting major oncology markets.ALXO
Corporate presentation3 Mar 2026 - Strong clinical progress, cost controls, and $150M financing extend cash runway through H1 2028.ALXO
Q4 202527 Feb 2026 - Evorpacept plus TRP nearly doubles response rates and durability in HER2+ gastric cancer.ALXO
Study Update13 Feb 2026 - Randomized breast cancer and novel EGFR ADC trials advance, with key data expected in 2026.ALXO
Jefferies Global Healthcare Conference 20253 Feb 2026 - Evorpacept plus TRP doubled response durability and improved outcomes in HER2+ gastric/GEJ cancer.ALXO
Study Result2 Feb 2026
Next ALX Oncology earnings date
Next ALX Oncology earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)